ProCE Banner Activity

Mitigating Health Disparities in Immune Checkpoint Inhibitor–Based Therapy: A Pharmacist’s Perspective

Clinical Thought

In this case-based commentary, we review pharmacist-driven strategies at the patient, provider, and healthcare system levels for overcoming health disparities among patients who receive immune checkpoint inhibitor–based therapy.

Released: July 06, 2022

Expiration: July 05, 2023

Share

Provided by

ProCE Banner

Supporters

Supported by education grants from

Bristol Myers Squibb

Merck Sharp & Dohme Corp.

Partners

AMCP

ProCE Banner